company background image
ONPH logo

Oncology Pharma OTCPK:ONPH Stock Report

Last Price

US$0.0001

Market Cap

US$3.9k

7D

9,900.0%

1Y

-99.9%

Updated

27 Mar, 2024

Data

Company Financials

ONPH Stock Overview

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics.

ONPH fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Oncology Pharma Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Oncology Pharma
Historical stock prices
Current Share PriceUS$0.0001
52 Week HighUS$1.05
52 Week LowUS$0.000001
Beta0
1 Month Change9,900.00%
3 Month Change9,900.00%
1 Year Change-99.94%
3 Year Change-100.00%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Shareholder Returns

ONPHUS BiotechsUS Market
7D9,900.0%0.9%0.4%
1Y-99.9%10.3%28.8%

Return vs Industry: ONPH underperformed the US Biotechs industry which returned 9.6% over the past year.

Return vs Market: ONPH underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is ONPH's price volatile compared to industry and market?
ONPH volatility
ONPH Average Weekly Movement12,030.7%
Biotechs Industry Average Movement11.6%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: ONPH's share price has been volatile over the past 3 months.

Volatility Over Time: ONPH's weekly volatility has decreased from 289540% to 12031% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1993n/aGeorge Malesekhttps://www.oncology-pharma.com

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019.

Oncology Pharma Inc. Fundamentals Summary

How do Oncology Pharma's earnings and revenue compare to its market cap?
ONPH fundamental statistics
Market capUS$3.87k
Earnings (TTM)-US$15.27k
Revenue (TTM)US$10.21k

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ONPH income statement (TTM)
RevenueUS$10.21k
Cost of RevenueUS$0
Gross ProfitUS$10.21k
Other ExpensesUS$25.48k
Earnings-US$15.27k

Last Reported Earnings

Mar 31, 2013

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did ONPH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.